EMEA (Europe, Middle East and Africa) Antimalarial Medication Market Report 2017

October 2017 | 101 pages | ID: EB9C66B4DD4PEN
QYResearch

Abstracts

In this report, the EMEA Antimalarial Medication market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (MT), revenue (Million USD), market share and growth rate of Antimalarial Medication for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Antimalarial Medication market competition by top manufacturers/players, with Antimalarial Medication sales volume (MT), price (USD/Kg), revenue (Million USD) and market share for each manufacturer/player; the top players including

• GlaxoSmithKline Plc
• Ranbaxy Laboratories
• Zydus Cadila
• Alvizia Health Care
• Bayer AG
• Pfizer, Inc.
• Ipca Laboratories Ltd
• Merck KGaA
• F. Hoffmann-La Roche AG
• Novartis AG

On the basis of product, this report displays the sales volume (MT), revenue (Million USD), product price (USD/Kg), market share and growth rate of each type, primarily split into

• By Mechanism of Action
• Resistance
• Prevention
• By Drug Type
• Quinine
• Chloroquine
• Pyrimethamine
• Amodiaquine
• Proguanil
• Mefloquine
• Sulfonamide
• Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (MT), market share and growth rate of Antimalarial Medication for each application, including

• Plasmodium Falciparum
• Plasmodium Vivax
• Plasmodium Malariae
• Plasmodium Ovale

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Antimalarial Medication Market Report 2017

1 ANTIMALARIAL MEDICATION OVERVIEW

1.1 Product Overview and Scope of Antimalarial Medication
1.2 Classification of Antimalarial Medication
  1.2.1 EMEA Antimalarial Medication Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Antimalarial Medication Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Resistance
  1.2.4 Prevention
1.3 EMEA Antimalarial Medication Market by Application/End Users
  1.3.1 EMEA Antimalarial Medication Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Plasmodium Falciparum
  1.3.3 Plasmodium Vivax
  1.3.4 Plasmodium Malariae
  1.3.5 Plasmodium Ovale
1.4 EMEA Antimalarial Medication Market by Region
  1.4.1 EMEA Antimalarial Medication Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Antimalarial Medication (2012-2022)
  1.5.1 EMEA Antimalarial Medication Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Antimalarial Medication Revenue and Growth Rate (2012-2022)

2 EMEA ANTIMALARIAL MEDICATION COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Antimalarial Medication Market Competition by Players/Manufacturers
  2.1.1 EMEA Antimalarial Medication Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Antimalarial Medication Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Antimalarial Medication Sale Price by Players (2012-2017)
2.2 EMEA Antimalarial Medication (Volume and Value) by Type/Product Category
  2.2.1 EMEA Antimalarial Medication Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Antimalarial Medication Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Antimalarial Medication Sale Price by Type (2012-2017)
2.3 EMEA Antimalarial Medication (Volume) by Application
2.4 EMEA Antimalarial Medication (Volume and Value) by Region
  2.4.1 EMEA Antimalarial Medication Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Antimalarial Medication Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Antimalarial Medication Sales Price by Region (2012-2017)

3 EUROPE ANTIMALARIAL MEDICATION (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Antimalarial Medication Sales and Value (2012-2017)
  3.1.1 Europe Antimalarial Medication Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Antimalarial Medication Revenue and Growth Rate (2012-2017)
3.2 Europe Antimalarial Medication Sales and Market Share by Type
3.3 Europe Antimalarial Medication Sales and Market Share by Application
3.4 Europe Antimalarial Medication Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Antimalarial Medication Sales Volume by Countries (2012-2017)
  3.4.2 Europe Antimalarial Medication Revenue by Countries (2012-2017)
  3.4.3 Germany Antimalarial Medication Sales and Growth Rate (2012-2017)
  3.4.4 France Antimalarial Medication Sales and Growth Rate (2012-2017)
  3.4.5 UK Antimalarial Medication Sales and Growth Rate (2012-2017)
  3.4.6 Russia Antimalarial Medication Sales and Growth Rate (2012-2017)
  3.4.7 Italy Antimalarial Medication Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Antimalarial Medication Sales and Growth Rate (2012-2017)

4 MIDDLE EAST ANTIMALARIAL MEDICATION (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Antimalarial Medication Sales and Value (2012-2017)
  4.1.1 Middle East Antimalarial Medication Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Antimalarial Medication Revenue and Growth Rate (2012-2017)
4.2 Middle East Antimalarial Medication Sales and Market Share by Type
4.3 Middle East Antimalarial Medication Sales and Market Share by Application
4.4 Middle East Antimalarial Medication Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Antimalarial Medication Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Antimalarial Medication Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Antimalarial Medication Sales and Growth Rate (2012-2017)
  4.4.4 Israel Antimalarial Medication Sales and Growth Rate (2012-2017)
  4.4.5 UAE Antimalarial Medication Sales and Growth Rate (2012-2017)
  4.4.6 Iran Antimalarial Medication Sales and Growth Rate (2012-2017)

5 AFRICA ANTIMALARIAL MEDICATION (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Antimalarial Medication Sales and Value (2012-2017)
  5.1.1 Africa Antimalarial Medication Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Antimalarial Medication Revenue and Growth Rate (2012-2017)
5.2 Africa Antimalarial Medication Sales and Market Share by Type
5.3 Africa Antimalarial Medication Sales and Market Share by Application
5.4 Africa Antimalarial Medication Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Antimalarial Medication Sales Volume by Countries (2012-2017)
  5.4.2 Africa Antimalarial Medication Revenue by Countries (2012-2017)
  5.4.3 South Africa Antimalarial Medication Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Antimalarial Medication Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Antimalarial Medication Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Antimalarial Medication Sales and Growth Rate (2012-2017)

6 EMEA ANTIMALARIAL MEDICATION MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 GlaxoSmithKline Plc
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Antimalarial Medication Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 GlaxoSmithKline Plc Antimalarial Medication Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Ranbaxy Laboratories
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Antimalarial Medication Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Ranbaxy Laboratories Antimalarial Medication Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Zydus Cadila
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Antimalarial Medication Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Zydus Cadila Antimalarial Medication Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Alvizia Health Care
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Antimalarial Medication Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Alvizia Health Care Antimalarial Medication Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Bayer AG
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Antimalarial Medication Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Bayer AG Antimalarial Medication Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Pfizer, Inc.
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Antimalarial Medication Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Pfizer, Inc. Antimalarial Medication Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Ipca Laboratories Ltd
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Antimalarial Medication Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Ipca Laboratories Ltd Antimalarial Medication Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Merck KGaA
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Antimalarial Medication Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Merck KGaA Antimalarial Medication Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 F. Hoffmann-La Roche AG
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Antimalarial Medication Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 F. Hoffmann-La Roche AG Antimalarial Medication Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Novartis AG
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Antimalarial Medication Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Novartis AG Antimalarial Medication Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 ANTIMALARIAL MEDICATION MANUFACTURING COST ANALYSIS

7.1 Antimalarial Medication Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Antimalarial Medication

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Antimalarial Medication Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Antimalarial Medication Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA ANTIMALARIAL MEDICATION MARKET FORECAST (2017-2022)

11.1 EMEA Antimalarial Medication Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Antimalarial Medication Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Antimalarial Medication Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Antimalarial Medication Price and Trend Forecast (2017-2022)
11.2 EMEA Antimalarial Medication Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Antimalarial Medication Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Antimalarial Medication Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Antimalarial Medication Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Antimalarial Medication Sales Forecast by Type (2017-2022)
11.7 EMEA Antimalarial Medication Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Antimalarial Medication
Figure EMEA Antimalarial Medication Sales Volume (MT) by Type (2012-2022)
Figure EMEA Antimalarial Medication Sales Volume Market Share by Type (Product Category) in 2016
Figure Resistance Product Picture
Figure Prevention Product Picture
Figure EMEA Antimalarial Medication Sales Volume (MT) by Application (2012-2022)
Figure EMEA Sales Market Share of Antimalarial Medication by Application in 2016
Figure Plasmodium Falciparum Examples
Table Key Downstream Customer in Plasmodium Falciparum
Figure Plasmodium Vivax Examples
Table Key Downstream Customer in Plasmodium Vivax
Figure Plasmodium Malariae Examples
Table Key Downstream Customer in Plasmodium Malariae
Figure Plasmodium Ovale Examples
Table Key Downstream Customer in Plasmodium Ovale
Figure EMEA Antimalarial Medication Market Size (Million USD) by Region (2012-2022)
Figure Europe Antimalarial Medication Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Antimalarial Medication Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Antimalarial Medication Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Antimalarial Medication Revenue (Million USD) Status and Forecast by Countries
Figure Africa Antimalarial Medication Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Antimalarial Medication Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Antimalarial Medication Sales Volume and Growth Rate (2012-2022)
Figure EMEA Antimalarial Medication Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Antimalarial Medication Market Major Players Product Sales Volume (MT) (2012-2017)
Table EMEA Antimalarial Medication Sales Volume (MT) of Major Players (2012-2017)
Table EMEA Antimalarial Medication Sales Share by Players (2012-2017)
Figure 2016 Antimalarial Medication Sales Share by Players
Figure 2017 Antimalarial Medication Sales Share by Players
Figure EMEA Antimalarial Medication Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Antimalarial Medication Revenue (Million USD) by Players (2012-2017)
Table EMEA Antimalarial Medication Revenue Share by Players (2012-2017)
Table 2016 EMEA Antimalarial Medication Revenue Share by Players
Table 2017 EMEA Antimalarial Medication Revenue Share by Players
Table EMEA Antimalarial Medication Sale Price (USD/Kg) by Players (2012-2017)
Table EMEA Antimalarial Medication Sales (MT) and Market Share by Type (2012-2017)
Table EMEA Antimalarial Medication Sales Share by Type (2012-2017)
Figure Sales Market Share of Antimalarial Medication by Type (2012-2017)
Figure EMEA Antimalarial Medication Sales Market Share by Type (2012-2017)
Table EMEA Antimalarial Medication Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Antimalarial Medication Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Antimalarial Medication by Type in 2016
Table EMEA Antimalarial Medication Sale Price (USD/Kg) by Type (2012-2017)
Table EMEA Antimalarial Medication Sales (MT) and Market Share by Application (2012-2017)
Table EMEA Antimalarial Medication Sales Share by Application (2012-2017)
Figure Sales Market Share of Antimalarial Medication by Application (2012-2017)
Figure EMEA Antimalarial Medication Sales Market Share by Application in 2016
Table EMEA Antimalarial Medication Sales (MT) and Market Share by Region (2012-2017)
Table EMEA Antimalarial Medication Sales Share by Region (2012-2017)
Figure Sales Market Share of Antimalarial Medication by Region (2012-2017)
Figure EMEA Antimalarial Medication Sales Market Share in 2016
Table EMEA Antimalarial Medication Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Antimalarial Medication Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Antimalarial Medication by Region (2012-2017)
Figure EMEA Antimalarial Medication Revenue Market Share Regions in 2016
Table EMEA Antimalarial Medication Sales Price (USD/Kg) by Region (2012-2017)
Figure Europe Antimalarial Medication Sales (MT) and Growth Rate (2012-2017)
Figure Europe Antimalarial Medication Revenue and Growth Rate (2012-2017)
Table Europe Antimalarial Medication Sales (MT) by Type (2012-2017)
Table Europe Antimalarial Medication Market Share by Type (2012-2017)
Figure Europe Antimalarial Medication Market Share by Type in 2016
Table Europe Antimalarial Medication Sales (MT) by Application (2012-2017)
Table Europe Antimalarial Medication Market Share by Application (2012-2017)
Figure Europe Antimalarial Medication Market Share by Application in 2016
Table Europe Antimalarial Medication Sales (MT) by Countries (2012-2017)
Table Europe Antimalarial Medication Sales Market Share by Countries (2012-2017)
Figure Europe Antimalarial Medication Sales Market Share by Countries (2012-2017)
Figure Europe Antimalarial Medication Sales Market Share by Countries in 2016
Table Europe Antimalarial Medication Revenue (Million USD) by Countries (2012-2017)
Table Europe Antimalarial Medication Revenue Market Share by Countries (2012-2017)
Figure Europe Antimalarial Medication Revenue Market Share by Countries (2012-2017)
Figure Europe Antimalarial Medication Revenue Market Share by Countries in 2016
Figure Germany Antimalarial Medication Sales (MT) and Growth Rate (2012-2017)
Figure France Antimalarial Medication Sales (MT) and Growth Rate (2012-2017)
Figure UK Antimalarial Medication Sales (MT) and Growth Rate (2012-2017)
Figure Russia Antimalarial Medication Sales (MT) and Growth Rate (2012-2017)
Figure Italy Antimalarial Medication Sales (MT) and Growth Rate (2012-2017)
Figure Benelux Antimalarial Medication Sales (MT) and Growth Rate (2012-2017)
Figure Middle East Antimalarial Medication Sales (MT) and Growth Rate (2012-2017)
Figure Middle East Antimalarial Medication Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Antimalarial Medication Sales (MT) by Type (2012-2017)
Table Middle East Antimalarial Medication Market Share by Type (2012-2017)
Figure Middle East Antimalarial Medication Market Share by Type (2012-2017)
Table Middle East Antimalarial Medication Sales (MT) by Applications (2012-2017)
Table Middle East Antimalarial Medication Market Share by Applications (2012-2017)
Figure Middle East Antimalarial Medication Sales Market Share by Application in 2016
Table Middle East Antimalarial Medication Sales Volume (MT) by Countries (2012-2017)
Table Middle East Antimalarial Medication Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Antimalarial Medication Sales Volume Market Share by Countries in 2016
Table Middle East Antimalarial Medication Revenue (Million USD) by Countries (2012-2017)
Table Middle East Antimalarial Medication Revenue Market Share by Countries (2012-2017)
Figure Middle East Antimalarial Medication Revenue Market Share by Countries (2012-2017)
Figure Middle East Antimalarial Medication Revenue Market Share by Countries in 2016
Figure Saudi Arabia Antimalarial Medication Sales (MT) and Growth Rate (2012-2017)
Figure Israel Antimalarial Medication Sales (MT) and Growth Rate (2012-2017)
Figure UAE Antimalarial Medication Sales (MT) and Growth Rate (2012-2017)
Figure Iran Antimalarial Medication Sales (MT) and Growth Rate (2012-2017)
Figure Africa Antimalarial Medication Sales (MT) and Growth Rate (2012-2017)
Figure Africa Antimalarial Medication Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Antimalarial Medication Sales (MT) by Type (2012-2017)
Table Africa Antimalarial Medication Sales Market Share by Type (2012-2017)
Figure Africa Antimalarial Medication Sales Market Share by Type (2012-2017)
Figure Africa Antimalarial Medication Sales Market Share by Type in 2016
Table Africa Antimalarial Medication Sales (MT) by Application (2012-2017)
Table Africa Antimalarial Medication Sales Market Share by Application (2012-2017)
Figure Africa Antimalarial Medication Sales Market Share by Application (2012-2017)
Table Africa Antimalarial Medication Sales Volume (MT) by Countries (2012-2017)
Table Africa Antimalarial Medication Sales Market Share by Countries (2012-2017)
Figure Africa Antimalarial Medication Sales Market Share by Countries (2012-2017)
Figure Africa Antimalarial Medication Sales Market Share by Countries in 2016
Table Africa Antimalarial Medication Revenue (Million USD) by Countries (2012-2017)
Table Africa Antimalarial Medication Revenue Market Share by Countries (2012-2017)
Figure Africa Antimalarial Medication Revenue Market Share by Countries (2012-2017)
Figure Africa Antimalarial Medication Revenue Market Share by Countries in 2016
Figure South Africa Antimalarial Medication Sales (MT) and Growth Rate (2012-2017)
Figure Nigeria Antimalarial Medication Sales (MT) and Growth Rate (2012-2017)
Figure Egypt Antimalarial Medication Sales (MT) and Growth Rate (2012-2017)
Figure Algeria Antimalarial Medication Sales (MT) and Growth Rate (2012-2017)
Table GlaxoSmithKline Plc Antimalarial Medication Basic Information List
Table GlaxoSmithKline Plc Antimalarial Medication Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Plc Antimalarial Medication Sales (MT) and Growth Rate (2012-2017)
Figure GlaxoSmithKline Plc Antimalarial Medication Sales Market Share in EMEA (2012-2017)
Figure GlaxoSmithKline Plc Antimalarial Medication Revenue Market Share in EMEA (2012-2017)
Table Ranbaxy Laboratories Antimalarial Medication Basic Information List
Table Ranbaxy Laboratories Antimalarial Medication Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Ranbaxy Laboratories Antimalarial Medication Sales (MT) and Growth Rate (2012-2017)
Figure Ranbaxy Laboratories Antimalarial Medication Sales Market Share in EMEA (2012-2017)
Figure Ranbaxy Laboratories Antimalarial Medication Revenue Market Share in EMEA (2012-2017)
Table Zydus Cadila Antimalarial Medication Basic Information List
Table Zydus Cadila Antimalarial Medication Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Zydus Cadila Antimalarial Medication Sales (MT) and Growth Rate (2012-2017)
Figure Zydus Cadila Antimalarial Medication Sales Market Share in EMEA (2012-2017)
Figure Zydus Cadila Antimalarial Medication Revenue Market Share in EMEA (2012-2017)
Table Alvizia Health Care Antimalarial Medication Basic Information List
Table Alvizia Health Care Antimalarial Medication Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Alvizia Health Care Antimalarial Medication Sales (MT) and Growth Rate (2012-2017)
Figure Alvizia Health Care Antimalarial Medication Sales Market Share in EMEA (2012-2017)
Figure Alvizia Health Care Antimalarial Medication Revenue Market Share in EMEA (2012-2017)
Table Bayer AG Antimalarial Medication Basic Information List
Table Bayer AG Antimalarial Medication Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Bayer AG Antimalarial Medication Sales (MT) and Growth Rate (2012-2017)
Figure Bayer AG Antimalarial Medication Sales Market Share in EMEA (2012-2017)
Figure Bayer AG Antimalarial Medication Revenue Market Share in EMEA (2012-2017)
Table Pfizer, Inc. Antimalarial Medication Basic Information List
Table Pfizer, Inc. Antimalarial Medication Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Pfizer, Inc. Antimalarial Medication Sales (MT) and Growth Rate (2012-2017)
Figure Pfizer, Inc. Antimalarial Medication Sales Market Share in EMEA (2012-2017)
Figure Pfizer, Inc. Antimalarial Medication Revenue Market Share in EMEA (2012-2017)
Table Ipca Laboratories Ltd Antimalarial Medication Basic Information List
Table Ipca Laboratories Ltd Antimalarial Medication Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Ipca Laboratories Ltd Antimalarial Medication Sales (MT) and Growth Rate (2012-2017)
Figure Ipca Laboratories Ltd Antimalarial Medication Sales Market Share in EMEA (2012-2017)
Figure Ipca Laboratories Ltd Antimalarial Medication Revenue Market Share in EMEA (2012-2017)
Table Merck KGaA Antimalarial Medication Basic Information List
Table Merck KGaA Antimalarial Medication Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Merck KGaA Antimalarial Medication Sales (MT) and Growth Rate (2012-2017)
Figure Merck KGaA Antimalarial Medication Sales Market Share in EMEA (2012-2017)
Figure Merck KGaA Antimalarial Medication Revenue Market Share in EMEA (2012-2017)
Table F. Hoffmann-La Roche AG Antimalarial Medication Basic Information List
Table F. Hoffmann-La Roche AG Antimalarial Medication Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche AG Antimalarial Medication Sales (MT) and Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche AG Antimalarial Medication Sales Market Share in EMEA (2012-2017)
Figure F. Hoffmann-La Roche AG Antimalarial Medication Revenue Market Share in EMEA (2012-2017)
Table Novartis AG Antimalarial Medication Basic Information List
Table Novartis AG Antimalarial Medication Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Novartis AG Antimalarial Medication Sales (MT) and Growth Rate (2012-2017)
Figure Novartis AG Antimalarial Medication Sales Market Share in EMEA (2012-2017)
Figure Novartis AG Antimalarial Medication Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antimalarial Medication
Figure Manufacturing Process Analysis of Antimalarial Medication
Figure Antimalarial Medication Industrial Chain Analysis
Table Raw Materials Sources of Antimalarial Medication Major Manufacturers in 2016
Table Major Buyers of Antimalarial Medication
Table Distributors/Traders List
Figure EMEA Antimalarial Medication Sales (MT) and Growth Rate Forecast (2017-2022)
Figure EMEA Antimalarial Medication Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Antimalarial Medication Price (USD/Kg) and Trend Forecast (2017-2022)
Table EMEA Antimalarial Medication Sales (MT) Forecast by Region (2017-2022)
Figure EMEA Antimalarial Medication Sales Market Share Forecast by Region (2017-2022)
Table EMEA Antimalarial Medication Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Antimalarial Medication Revenue Market Share Forecast by Region (2017-2022)
Table Europe Antimalarial Medication Sales (MT) Forecast by Countries (2017-2022)
Figure Europe Antimalarial Medication Sales Market Share Forecast by Countries (2017-2022)
Table Europe Antimalarial Medication Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Antimalarial Medication Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Antimalarial Medication Sales (MT) Forecast by Countries (2017-2022)
Figure Middle East Antimalarial Medication Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Antimalarial Medication Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Antimalarial Medication Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Antimalarial Medication Sales (MT) Forecast by Countries (2017-2022)
Figure Africa Antimalarial Medication Sales Market Share Forecast by Countries (2017-2022)
Table Africa Antimalarial Medication Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Antimalarial Medication Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Antimalarial Medication Sales (MT) Forecast by Type (2017-2022)
Figure EMEA Antimalarial Medication Sales Market Share Forecast by Type (2017-2022)
Table EMEA Antimalarial Medication Sales (MT) Forecast by Application (2017-2022)
Figure EMEA Antimalarial Medication Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources